Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SHOE
2326
Shoe Station Group
SHOE
$413M
| $7.85M | ﹤0.01% |
241,997
+159,847
| +195% | +$5.57M |
|
2327
Seanergy Maritime Holdings
SHIP
$379M
| $7.79M | ﹤0.01% |
537,546
+506,573
| +1,636% | +$5.92M |
|
2328
Coherus Oncology
CHRS
$217M
| $7.78M | ﹤0.01% |
484,025
+235,903
| +95% | +$3.46M |
|
2329
CALL
Truist Financial
TFC
$63.3B
| $7.78M | ﹤0.01% |
+132,600
| New | +$7.41M |
|
|
ETWO
2330
DELISTED
E2open Parent Holdings
ETWO
| $7.77M | ﹤0.01% |
687,889
-771,899
| -53% | -$8.67M |
|
|
VYGG
2331
DELISTED
Vy Global Growth
VYGG
| $7.77M | ﹤0.01% |
791,815
-558,887
| -41% | -$5.48M |
|
2332
PUT
DexCom
DXCM
$31.5B
| $7.76M | ﹤0.01% |
56,800
-277,200
| -83% | -$35M |
|
|
KCAC
2333
DELISTED
Kensington Capital Acquisition Corp. II
KCAC
| $7.75M | ﹤0.01% |
936,501
+271,274
| +41% | +$2.68M |
|
|
AIV
2334
Aimco
AIV
$387M
| $7.75M | ﹤0.01% |
1,131,047
-980,628
| -46% | -$6.75M |
|
2335
Albertsons Companies
ACI
$5.62B
| $7.74M | ﹤0.01% |
248,604
-578,900
| -70% | -$15.2M |
|
2336
Stantec
STN
$8.04B
| $7.73M | ﹤0.01% |
164,424
+138,200
| +527% | +$6.55M |
|
2337
Iron Mountain
IRM
$36.4B
| $7.73M | ﹤0.01% |
177,834
-169,402
| -49% | -$7.62M |
|
|
BWIN
2338
Baldwin Insurance Group
BWIN
$2.69B
| $7.73M | ﹤0.01% |
232,123
+58,414
| +34% | +$1.83M |
|
|
FSRD
2339
DELISTED
Fast Radius, Inc. Class A Common Stock
FSRD
| $7.71M | ﹤0.01% |
780,734
+225,763
| +41% | +$2.22M |
|
2340
Selective Insurance
SIGI
$5.65B
| $7.71M | ﹤0.01% |
102,076
+40,026
| +65% | +$3.22M |
|
2341
Oceaneering
OII
$4.86B
| $7.7M | ﹤0.01% |
+578,063
| New | +$7.54M |
|
2342
CALL
ResMed
RMD
$30.6B
| $7.7M | ﹤0.01% |
29,200
-10,800
| -27% | -$2.95M |
|
|
FRGE
2343
DELISTED
Forge Global Holdings
FRGE
| $7.69M | ﹤0.01% |
51,811
+12,403
| +31% | +$1.82M |
|
|
SDC
2344
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $7.69M | ﹤0.01% |
1,445,460
+576,143
| +66% | +$3.58M |
|
2345
Brady Corp
BRC
$4.44B
| $7.69M | ﹤0.01% |
151,609
+111,730
| +280% | +$5.89M |
|
2346
ePlus
PLUS
$2.42B
| $7.68M | ﹤0.01% |
149,776
+87,630
| +141% | +$4.33M |
|
|
SAFE
2347
DELISTED
Safehold Inc.
SAFE
| $7.66M | ﹤0.01% |
106,608
+76,133
| +250% | +$6.46M |
|
2348
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
| $7.66M | ﹤0.01% |
87,586
-77,816
| -47% | -$6.83M |
|
2349
CALL
Globus Medical
GMED
$10.7B
| $7.66M | ﹤0.01% |
100,000
+50,000
| +100% | +$4.01M |
|
2350
CALL
International Flavors & Fragrances
IFF
$20.2B
| $7.65M | ﹤0.01% |
57,200
+11,000
| +24% | +$1.62M |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.